An anti-retroviral treatment programme for the millions of people infected with HIV and Aids is "a reality" - and not a matter of if, but when.
In a dramatic closing statement at the South African Aids Conference in Durban on Wednesday, the MEC for health in KwaZulu-Natal, Dr Zwele Mkhize, said the government was committed to a comprehensive plan of Aids treatment for the country.
"There is no question about this," Mkhize said. "It must be placed on record that this is not an ideological issue. With the rising mortality rate from Aids, one more death is one too many."
Continues Below ↓
Mkhize said he was speaking on behalf of Health Minister Manto Tshabalala-Msimang, who was unable to address delegates at the close of the conference because she was out of the country.
'One more death is one too many' In another breakthrough, government sources confirmed that President Thabo Mbeki had signed the long-awaited Global Fund agreements, which will see more than R500-million coming to KZN to support a wide range of programmes, including the provision of anti-retroviral treatment.
The only signature outstanding was that of Deputy President Jacob Zuma, who is expected to sign the agreements "either today or tomorrow" after he returns from a trip to Tanzania.
The cabinet also announced on Wednesday that South Africa's first generic anti-retroviral drugs - up to 41 percent cheaper than the original - were being manufactured.
Manufacturer Aspen Pharmacare said it hoped the drug, Aspen-Stavudine, would eventually form part of a cocktail for Aids patients costing less than $1 (about R7) a day.
It has, to this end, applied to the Medicines Control Council to be allowed to also manufacture generics of the drugs Didanosine, Combivir, AZT, 3TC and nevirapine.
'The value of nevirapine to save babies' lives cannot be undermined' The cabinet welcomed the fact that Aspen had reached the stage of production of some generic anti-retroviral drugs in South Africa.
Continues...
|
StumbleUpon
Reddit
Digg
Delicious
Newsvine
Facebook
muti
Twitter
